Effect of desflurane, sevoflurane or propofol on the incidence of postoperative delirium in older adults undergoing moderate- to high-risk major non-cardiac surgery: study protocol for a prospective, randomised, observer-blinded, clinical trial (RAPID-II trial)

Alexander Taschner, Edith Fleischmann, Barbara Kabon, Barbara Sinner, Christine Eckhardt, Katharina Horvath, Nikolas Adamowitsch, Nicole Hantakova, Beatrix Hochreiter, Oliver Zotti, Melanie Fraunschiel, Alexandra Graf, Christian Reiterer, Nikolas Adamowitsch · 2024

Read Effect of desflurane, sevoflurane or propofol on the incidence of postoperative delirium in older adults undergoing moderate- to high-risk major non-cardiac surgery: study protocol for a prospective, randomised, observer-blinded, clinical trial (RAPID-II trial) by Alexander Taschner, Edith Fleischmann, Barbara Kabon, Barbara Sinner, Christine Eckhardt, Katharina Horvath, Nikolas Adamowitsch, Nicole Hantakova, Beatrix Hochreiter, Oliver Zotti, Melanie Fraunschiel, Alexandra Graf, Christian Reiterer, Nikolas Adamowitsch (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11603681.txt.

Description

Taschner and co-authors set out the protocol for the RAPID-II trial, which tests whether the choice of anesthetic affects delirium after surgery in older adults. Delirium is a common and serious confusion state after major operations, and earlier evidence does not settle which maintenance drug is safest for the brain. The trial will enroll 1,332 patients aged 65 and over having major non-cardiac surgery of at least two hours, at several centers.

Patients are assigned at random to desflurane, sevoflurane, or propofol, with brain monitoring guiding depth. Trained staff, blinded to the assignment, check for delirium morning and evening for five days. The team will also compare slower thinking recovery, longer-term cognitive problems, and nausea. The protocol records ethics approvals and a 2023 registration; the catalog byline repeats one investigator's name.

Catalog record

CREATORAlexander Taschner, Edith Fleischmann, Barbara Kabon, Barbara Sinner, Christine Eckhardt, Katharina Horvath, Nikolas Adamowitsch, Nicole Hantakova, Beatrix Hochreiter, Oliver Zotti, Melanie Fraunschiel, Alexandra Graf, Christian Reiterer, Nikolas Adamowitsch
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11603681

Browse the full library · About the Tower of Babel